Foresite Capital Management V’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,811,887
| Closed | -$19.6M | – | 10 |
|
|
2023
Q2 | $19.6M | Buy |
10,811,887
+773,952
| +8% | +$1.4M | 14.29% | 3 |
|
|
2023
Q1 | $13.3M | Hold |
10,037,935
| – | – | 9.79% | 3 |
|
|
2022
Q4 | $17M | Buy |
10,037,935
+637,420
| +7% | +$1.08M | 13.18% | 5 |
|
|
2022
Q3 | $17.4M | Hold |
9,400,515
| – | – | 13.37% | 4 |
|
|
2022
Q2 | $28.9M | Hold |
9,400,515
| – | – | 20.16% | 1 |
|
|
2022
Q1 | $67.9M | Hold |
9,400,515
| – | – | 27.72% | 1 |
|
|
2021
Q4 | $154M | Buy |
9,400,515
+8,798,015
| +1,460% | +$144M | 37.81% | 1 |
|
|
2021
Q3 | $6M | Hold |
602,500
| – | – | 1.86% | 13 |
|
|
2021
Q2 | $6.01M | Hold |
602,500
| – | – | 2.37% | 13 |
|
|
2021
Q1 | $6M | Buy |
+602,500
| New | +$6M | 1.76% | 12 |
|